Epstein-Barr virus nuclear antigen-2 detection and typing in immunocompromised children correlated with lymphoproliferative disorder biopsy findings

Epstein-Barr virus nuclear antigen-2 detection and typing in immunocompromised children correlated with lymphoproliferative disorder biopsy findings

Autor Mendes, Thiago Marques Google Scholar
Oliveira, Lea Campos de Google Scholar
Yamamoto, Lídia Autor UNIFESP Google Scholar
Del Negro, Gilda Maria Barbaro Google Scholar
Okay, Thelma Suely Google Scholar
Instituição Universidade Federal de São Paulo (UNIFESP)
Resumo Epstein-Barr virus (EBV), the causative agent of infectious mononucleosis, plays a significant role as a cofactor in the process of tumorigenesis, and has consistently been associated with a variety of malignancies especially in immunocompromised patients. Forty-four children and adolescents (21 liver transplant patients, 7 heart transplant, 5 AIDS, 3 autoimmune hepatitis, 2 nephritic syndromes, 2 medullar aplasia, 2 primary immunodeficiency disorder patients, 1 thrombocytopenic purpura and 1 systemic lupus erythematosus) presenting with chronic active EBV infection (VCA-IgM persistently positive; VCA-IgG > 20 AU/mL and positive IgG - EBNA) had peripheral blood samples obtained during clinically characterized EBV reactivation episodes. DNA samples were amplified in order to detect and type EBV on the basis of the EBNA-2 sequence (EBNA2 protein is essential for EBV-driven immortalization of B lymphocytes). Although we have found a predominance of type 1 EBNA-2 virus (33/44; 75%), 10 patients (22.73%) carried type 2 EBNA-2, and one liver transplant patient (2.27%) a mixture of the two types, the higher proportion of type 2 EBV, as well as the finding of one patient bearing the two types is in agreement with other reports held on lymphoproliferative disorder (LPD) patients, which analyzed tumor biopsies. We conclude that EBNA-2 detection and typing can be performed in peripheral blood samples, and the high prevalence of type 2 in our casuistic indicates that this population is actually at risk of developing LPD, and should be monitored.
Palavra-chave EBVA
EBNA-2
infectious mononucleosis
lymphoproliferative disorder
EBV genotyping
EBV-PCR
Idioma Inglês
Data de publicação 2008-06-01
Publicado em Brazilian Journal of Infectious Diseases. Salvador: Contexto, v. 12, n. 3, p. 186-191, 2008.
ISSN 1413-8670 (Sherpa/Romeo, fator de impacto)
Publicador Contexto
Extensão 186-191
Fonte http://dx.doi.org/10.1590/S1413-86702008000300005
Direito de acesso Acesso aberto Open Access
Tipo Artigo
Web of Science WOS:000259751400005
SciELO S1413-86702008000300005 (estatísticas na SciELO)
Endereço permanente http://repositorio.unifesp.br/handle/11600/30680

Exibir registro completo




Arquivo

Arquivo Tamanho Formato Visualização

Não existem arquivos associados a este item.

Este item está nas seguintes coleções

Buscar


Navegar

Minha conta